The Belt and Road: Cooperation, Harmony and Win-Win
products

Nutraceutical

  • β-Nicotinamide Adenine Dinucleotide Lithium salt (NAD Lithium salt)  CAS:64417-72-7

    β-Nicotinamide Adenine Dinucleotide Lithium salt (NAD Lithium salt) CAS:64417-72-7

    β-Nicotinamide Adenine Dinucleotide Lithium salt is a coenzyme central to metabolism.Found in all living cells, NAD is called a dinucleotide because it consists of two nucleotides joined through their phosphate groups. One nucleotide contains an adenine nucleobase and the other nicotinamide. NAD exists in two forms: an oxidized and reduced form, abbreviated as NAD+ and NADH (H for hydrogen), respectively.

  • Venlafaxine  CAS:93413-69-5

    Venlafaxine CAS:93413-69-5

    Venlafaxine is an antidepressant of the serotonin and norepinephrine reuptake inhibitor (SNRI) class. This drug was first developed by Wyeth in 19Chemicalbook93 and is now marketed by Pfizer. This drug is approved for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and depression associated with anxiety.

  • β-Nicotinamide Mononucleotide  CAS:1094-61-7

    β-Nicotinamide Mononucleotide CAS:1094-61-7

    Nicotinamide mononucleotide (NMN), a product of the NAMPT reaction and a key NAD+ intermediate, ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. NMN also enhances hepatic insulin sensitivity and restores gene expression related to oxidative stress, inflammatory response, and circadian rhythm, partly through SIRT1 activation. NMN is used for studying binding motifs within RNA aptamers and ribozyme activation processes involving β-nicotinamide mononucleotide (β-NMN)-activated RNA fragments.

  • β-Nicotinamide Adenine Dinucleotide  CAS:53-84-9

    β-Nicotinamide Adenine Dinucleotide CAS:53-84-9

    β-Nicotinamide adenine dinucleotide (NAD) is the oxidized form of β-Nicotinamide Adenine Dinucleotide. It exists as an anion under normal physio-logic conditions. It is functionally related to a deamido-NAD zwitterion. It is a conjugate base of a NAD(+). It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH).

  • β-Nicotinamide Adenine Dinucleotide, reduced form CAS:606-68-8

    β-Nicotinamide Adenine Dinucleotide, reduced form CAS:606-68-8

    β-Nicotinamide adenine dinucleotide (NAD+) and β-Nicotinamide adenine dinucleotide, reduced (NADH) comprise a coenzyme redox pair (NAD+:NADH) involved in a wide range of enzyme catalyzed oxidation reduction reactions. In addition to its redox function, NAD+/NADH is a donor of ADP-ribose units in ADP-ribosylaton (ADP-ribosyltransferases; poly(ADP-ribose) polymerases ) reactions and a precursor of cyclic ADP-ribose (ADP-ribosyl cyclases).

  • β-Nicotinamide Adenine Dinucleotide Phosphate Tetrasodium Salt, reduced form  CAS:2646-71-1

    β-Nicotinamide Adenine Dinucleotide Phosphate Tetrasodium Salt, reduced form CAS:2646-71-1

    NADPH is the reduced form of the coenzyme NADP+; used in anabolic reactions such as lipid and nucleic acid synthesis, which require NADPH as a reducing agent.NADPH, Tetrasodium Salt is a A ubiquitous coenzyme that acts as an electron donor in many reactions utilizing dehydrogenase and reductase enzymes. It is generated by reduction of the electron acceptor NADP+. The following biological pathways involve NADPH: formation of carbohydrate from CO2 during photosynthesis, maintenance of high levels of reduced glutathione in erythrocytes, reduction of thioredoxin.

  • Thio-Nicotinamide Adenine Dinucleotide (Thio-NAD) CAS:4090-29-3

    Thio-Nicotinamide Adenine Dinucleotide (Thio-NAD) CAS:4090-29-3

    Thionicotinamide adenine dinucleotide is an analog of NAD. Use of Thio-NAD instead of NAD as a substrate for NAD(+)-consuming enzymes is more advantageous since the reduced form of Thio-NAD exhibits a substantial increase in absorbance at 405 nM, the most commonly available wavelength on microplate readers.

  • β-Nicotinamide Adenine Dinucleotide Phosphate Monosodium Salt  CAS:1184-16-3

    β-Nicotinamide Adenine Dinucleotide Phosphate Monosodium Salt CAS:1184-16-3

    Nicotinamide adenine dinucleotide phosphate, abbreviated NADP+ or, in older notation, TPN (triphosphopyridine nucleotide), is a cofactor used in anabolic reactions, such as the Calvin cycle and lipid and nucleic acid syntheses, which require NADPH as a reducing agent (‘hydrogen source’).It is used by all forms of cellular life.

  • β-Nicotinamide Adenine Dinucleotide Phosphate Disodium Salt  CAS:24292-60-2

    β-Nicotinamide Adenine Dinucleotide Phosphate Disodium Salt CAS:24292-60-2

    β-Nicotinamide Adenine Dinucleotide Phosphate Disodium Salt  is a coenzyme that is widely distributed in living matter, Participates in oxidation-reduction reactions. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH).β-Nicotinamide Adenine Dinucleotide Phosphate Disodium Salt  is a substance in which nicotinic acid amide adenine dinucleotide and a phosphate molecule are bound by ester bond. It is a hydrogen receptor and can be used for the development and development of a variety of in vitro diagnostic reagents.

  • Ciclopirox Ethanolamine  CAS:41621-49-2  Manufacturer Supplier

    Ciclopirox Ethanolamine CAS:41621-49-2 Manufacturer Supplier

    Ciclopirox ethanolamine is a broad spectrum antigfungal agent, it also exhibits antibacterial activity against many Gram-positive and Gram-negative bacteria, and has anti-inflammatory properties. It is used a a topical treatment of fungal skin an nail infections.

  • Desvenlafaxine Succinate  CAS:386750-22-7

    Desvenlafaxine Succinate CAS:386750-22-7

    Desvenlafaxine Succinate is a dual serotonin and norepinephrine reuptake inhibitor (SNRI) that was approved for the treatment of major depressive disorder (MDD) in the United States in 2008. In order to improve the efficacy and safety profile of venlafaxine, Wyeth discovered and developed one of the major metabolites of venlafaxine, namely the O-desmethyl metabolite (desvenlafaxine).

  • Doxazosin Mesylate  CAS:77883-43-3 Manufacturer Supplier

    Doxazosin Mesylate CAS:77883-43-3 Manufacturer Supplier

    Doxazosin mesylate is a quinazoline compound that is a selective inhibitor of the alpha1 subtype of alpha adrenergic receptors. Doxazosin mesylate is a new generation of quinazolone α1 receptor blocker developed by the Pfizer company (United States), It has a long half-life, exerting its effects of dilating the blood vessels, reducing the vascular resistance and lowering the blood pressure through blocking the a 1 receptor.  It has been recommended abroad as first-line clinical drugs of anti-hypertension and treatment of prostate disease.